The global viral clearance services market was valued at USD 974.13 Million in 2025 driven by the rising prevalence of chronic diseases, and advancements in biotechnology across the globe. It is expected to grow at a CAGR of 14.20% during the forecast period of 2026-2035 and attain a market value of USD 3675.17 Million by 2035.
Base Year
Historical Period
Forecast Period
The market is expected to witness growth due to rising demand for biologics and gene therapies and increasing regulatory demands on biopharmaceutical safety.
In December 2023, Summit Pharmaceuticals partnered with Texcell Japan to enhance viral clearance capabilities. This collaboration reflects the market’s focus on strengthening manufacturing processes and complying with regulatory standards, fostering market reliability and innovation.
North America is projected to lead the market due to a well-established biopharmaceutical infrastructure and an emphasis on regulatory compliance, which is driving regional growth.
Viral clearance services ensure the complete removal or inactivation of viruses in biopharmaceutical production, thus assuring the safety and efficacy of the product. Key drivers of growth of the market are increasing demand for biologics, gene therapy, and rising incidences of chronic diseases. Several trends such as regulatory compliance, biotechnology innovations, and strategic partnerships continue to propel the market growth. The market holds significant growth potential, fueled by advancements in biotechnology and rising investments in innovative next-generation therapies.
Rising Prevalence of Chronic Disease Boost the Market Demand
The growing prevalence of chronic diseases has become a significant driver of market expansion. Conditions such as cancer, diabetes, and autoimmune disorders require the implementation of advanced biologics and gene therapies, which are governed by stringent viral safety protocols to comply with regulatory standards and protect patient health. The growing burden of these chronic diseases raises the demand for new therapeutics alongside the need for effective viral clearance procedures to mitigate the contamination risks during manufacturing.
Several trends and developments are being observed in the market to enhance the current situation. Some of the noteworthy trends are as follows:
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Method
Market Breakup by Application
Market Breakup by End User
Market Breakup by Region
Market Share by Method to Witness Significant Growth
Based on method, the market is divided into viral removal method, viral inactivation method, and others. Among these, the viral removal method is expected to dominate the market due to its superior efficacy in the physical elimination of viruses from biotherapeutics, thereby ensuring product safety. This technique has gained prominence within the biopharmaceutical sector, driven by advancements in filtration and chromatography technologies. The viral removal approach not only meets evolving safety regulations but also offers innovative solutions that will likely facilitate market expansion during the forecast period.
Regionally, the market is divided into North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Among these, North America is expected to dominate the market due to its well-established biopharmaceutical infrastructure. For instance, in June 2023, Texcell announced its new 27,000-square-foot viral clearance testing facility in Frederick, Maryland. This facility exemplifies advanced infrastructure dedicated to improving viral safety protocols for monoclonal antibodies, gene therapies, and medical devices. Designed with a modular layout, it provides the flexibility required for simultaneous viral clearance and biosafety studies, addressing the evolving demands of the contract testing landscape. Such initiatives reinforce regulatory compliance, ultimately contributing to the overall growth and resilience of the market.
The key features of the market report include grants analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies are:
Established in 1947 and headquartered in Wilmington, Massachusetts, Charles River Laboratories is a global leader in drug development services. Its viral clearance product portfolio includes comprehensive validation studies to ensure the safety and efficacy of biopharmaceutical products. Key offerings include virus filtration, inactivation, and clearance testing services, which are part of their biologics testing solutions.
Founded in 1971 and based in Ochsenhausen, Germany, Labor Dr. Merk & Kollegen GmbH specializes in GLP and GMP-certified biosafety testing. Their expertise includes viral clearance services for viral vectors, oncolytic viruses, and biopharmaceutical products. The company offers tailored solutions for virus inactivation and filtration, ensuring compliance with international regulatory standards. Their reputation lies in supporting the development of innovative therapeutic solutions with a strong focus on viral safety.
Established in 1668 and headquartered in Darmstadt, Germany, Merck KGaA is a pioneer in life sciences and biopharmaceutical services. Through its BioReliance® portfolio, Merck provides viral clearance testing, including virus filtration and inactivation services. Their innovative solutions, such as the recently launched Deviron™ detergents, cater to evolving regulatory demands and biopharmaceutical manufacturing needs, emphasizing compliance, safety, and efficiency in viral clearance processes.
Founded in 1987 and headquartered in France, Texcell SA is a global leader in viral safety testing and viral clearance studies. Their product portfolio includes biosafety testing for monoclonal antibodies, gene therapies, and vaccines. Texcell’s expertise spans over 35 years, offering robust viral inactivation and filtration services. The company is renowned for supporting the development and regulatory compliance of biopharmaceuticals and medical devices worldwide.
*Please note that this is only a partial list; the complete list of key players is available in the full report. Additionally, the list of key players can be customized to better suit your needs.*
Other key players in the market include WuXi AppTec Co., Ltd., Sartorius AG, Eurofins Scientific, Syngene International Limited, and Lonza AG.
Upto 15% Off
USD
$3299 $2969
$5499 $4949
$6999 $5949
$8199 $6969
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Explore our key highlights of the report and gain a concise overview of key findings, trends, and actionable insights that will empower your strategic decisions.
| REPORT FEATURES | DETAILS |
| Base Year | 2025 |
| Historical Period | 2019-2025 |
| Forecast Period | 2026-2035 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Method |
|
| Breakup by Application |
|
| Breakup by End User |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Supplier Landscape |
|
| Companies Covered |
|
Datasheet
One User
USD 3,299
USD 2,969
tax inclusive*
Single User License
One User
USD 5,499
USD 4,949
tax inclusive*
Five User License
Five User
USD 6,999
USD 5,949
tax inclusive*
Corporate License
Unlimited Users
USD 8,199
USD 6,969
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Share